Table 3.
Mean ratios (between AZD8848 and placebo) for levels of α2-macroglobulin and tryptase, respectively, in nasal lavages obtained 24 hours after the last allergen challenge in the repeat challenge/treatment study
| Variable | Mean ratio | 95% CI | P-value |
|---|---|---|---|
| α2-Macroglobulin |
0.50 |
0.25-0.97 |
0.020 |
| Tryptase | 0.62 | 0.35-1.10 | 0.049 |
α2-Macroglobulin was reduced in patients who had received AZD8848 (p < 0.05, c.f. placebo). Similarly, lower levels of tryptase were observed in this group (p < 0.05, c.f. placebo).